Cuprina Holdings Limited

Cuprina Holdings Limited is on the Cruelty Free Investing use of animals list because they are directly involved in the use and commercialization of live and animal-derived materials for its medical products. Additionally, their pipeline includes products utilizing bullfrog collagen derived from abattoir waste streams and products using medical leeches for wound treatment.

Supporting Evidence:

The company confirms in the following report that they are involved in the use of animal by-products and the cultivation of insects for medical treatment.

“As of June 30, 2024, we manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.” (Page 3) Read the full document